HPV jab is effective in sexually active women
08 June 2007
Vaccination against human papilloma virus (HPV) could significantly reduce rates of cervical cancer even among women previously exposed to the virus, claim US researchers.
The study involved 20,583 women, aged 15-26, who were randomly assigned the quadrivalent HPV vaccine, the HPV16 component of the vaccine or placebo.
Over three years, the women underwent Papanicolaou testing with colposcopy or biopsy if abnormalities were detected.
Among the 17,129 women who tested negative for HPV 16/18, the vaccine had an efficacy of 99 per cent for preventing HPV16/18-related cancerous cervical lesions.
In an intention-to-treat analysis of all women, the vaccine had an efficacy of 44 per cent.
What do you think? Comment below or email us at healthcare.republic@haymarket.com
Additional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
- Locum GP Leeds and Surrounding Area Pegasus Medical £70 - £75 per hour, Leeds and Yorkshire long term
- Locums GP Walsall Pegasus Medical £70 per hour, Walsall and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
